Does Jardiance (empagliflozin) increase or cause atrial fibrillation (AFib)?
Jardiance is an SGLT2 inhibitor used for type 2 diabetes and certain heart conditions. The provided information does not include any specific evidence about whether Jardiance causes atrial fibrillation or changes AFib risk.
If you’re asking because you or someone you’re treating has AFib symptoms or a new AFib diagnosis, the safest next step is to review the prescribing information and current clinical guidance for empagliflozin plus your individual heart history with a clinician.
What do people mean by “Jardiance and AFib” in practice?
Searches for “Jardiance and afib” often reflect a few different concerns:
- A new AFib diagnosis after starting Jardiance
- Worries that low blood pressure, dehydration, or electrolyte shifts could trigger arrhythmias
- Whether Jardiance (and other SGLT2 inhibitors) is safe to use in people with known atrial arrhythmias
- Questions about blood thinner or rate/rhythm medication interactions (no direct interaction details are provided here)
If you tell me the context (new AFib after starting? existing AFib? heart failure? diabetes?), I can narrow the answer to the most relevant concern.
Is Jardiance recommended in people with heart failure or cardiovascular disease who have AFib?
Jardiance is commonly used in people with heart failure and cardiovascular risk, including many patients who also have atrial fibrillation. However, the provided information does not specify AFib-specific recommendations or outcomes.
Could Jardiance affect heart rhythm indirectly?
People often connect AFib to possible medication effects like:
- changes in volume status (diuresis)
- blood pressure lowering
- effects on kidney function and overall physiologic stress
Your individual risk depends on factors like dose, hydration, other medications (especially diuretics), kidney function, and baseline heart rhythm stability. The provided information doesn’t include Jardiance-specific mechanistic or trial-level AFib data.
If I have AFib, what should I watch for while taking Jardiance?
Common practical monitoring points clinicians consider when patients start or continue SGLT2 inhibitors include symptoms that could signal cardiovascular instability or worsening illness. If you develop palpitations, rapid heart rate, dizziness, chest discomfort, or worsening shortness of breath, seek medical evaluation promptly, especially if symptoms are new or severe.
What would a doctor consider instead of Jardiance if AFib risk is a concern?
If AFib is a high concern, clinicians may weigh alternatives based on why Jardiance is being used (diabetes control, heart failure benefit, kidney protection). Which option makes sense depends on your diagnosis and comorbidities. The provided information does not list Jardiance alternatives or comparative AFib risk.
Sources
No sources were provided with your question. If you share the specific document or label excerpt you’re working from (or the clinical guideline/trial name you saw), I can synthesize it directly.
If you want, reply with:
1) Are you asking about new AFib after starting Jardiance or about safety with existing AFib?
2) Your dose and how long you’ve been on it
3) Whether you have heart failure or diabetes only
and I’ll tailor the answer.